Enhanced External Counterpulsaton(EECP): Shahid Gangalal Natonal Heart Center experience in frst nine patents
Journal Title: Nepalese Heart Journal - Year 2011, Vol 8, Issue 1
Abstract
Background EECP is a novel; FDA approved; non-invasive; outpatent treatment offered to patents with refractory angina pectoris (RAP).It uses sequentally inflated pneumatc cuffs on the lower extremites to enhance coronary diastolic flow. We studied its effect in eight patents with refractory angina pectoris. Methods All patents (n=9) who were referred for EECP to Shahid Gangalal Natonal Heart Centre who completed a treatment course (one hour per day for 35 days) of EECP and underwent 6-minute walk test before and afer treatment were included. Demographic data, coronary artery disease (CAD) risk factors and baseline angiographic data were collected. Distance covered in six minute walk test before and afer the treatment was compared. Results All the patents who had undergone EECP had a positve clinical response. Distance covered in Six minute walk test improved in all patents afer the treatment. Decrease in anginal severity, frequency and the use of sublingual nitrates, with improvement in quality of life was observed afer the treatment. During the treatment some patents complained of leg pain, one patent develops blister and one ecchymosis but the treatment was not discontnued. Conclusion The results from these patents suggest that EECP is an effectve, safe and well tolerated treatment opton for the patents with RAP.
Authors and Affiliations
Adhikari CM| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Prajapat D| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Rauniyar B| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,NepalDepartment of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Maskey A| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, KC MB| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal
Keywords
Related Articles
- EP ID EP15702
- DOI http://dx.doi.org/10.3126/njh.v8i1.8337
- Views 414
- Downloads 16
Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD) Prevention and COntrol Program in Nepal
Ministry of Health and population, Government of Nepal announced the launch of National program for prevention and control of RF/RHD in Nepal in Ashad 2063 BS. Implementation of this program started on 15 Ashad 2064 with...
Immediate Outcome of Percutaneous Balloon Mitral Valvotomy in Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal
background and aim: Percutaneous balloon mitral valvotomy is well established as safe and effective procedure for patients with mitral stenosis due to Rheumatic Heart Disease. There are some retrospective studies on...
Prosthetic valve thrombosis in a tertiary cardiac centre
Background and Aims: Prosthetic valve thrombosis remains a major complication of valve replacement surgeries in Nepal. A number of patients present with thrombotic complications mainly due to poor anticoagulation status...
Outcome of pregnancies in women with prosthetic mechanical heart valves
Background and Aims: Rheumatic heart disease is still prevalent in Nepal. Many young women had to undergo cardiac surgery before or at their childbearing age. Due to teratogenic effect and maternal risk, pregnancy is g...
Epidemiological survey of Rheumatic fever, Rheumatic heart disease and Congenital heart disease among school children in Kathmandu valley of Nepal
background and aims: Rheumatic Fever, Rheumatic Heart Disease and Congenital Heart disease are the most common cardiac problems in school children. Prior studies have reported different prevalence rate of Rheumatic He...